Désolé, cet article est seulement disponible en EN.
Cliquez pour voir le graph
Connexions
Cliquez pour voir la ligne de temps
Ligne de temps
Présentation
Projets Transversaux
Projets
Anciennes Équipes
Publications
Télécharger-
2024Generation of IPi002-A/B/C human induced pluripotent stem cell lines from MARCH amniotic fluid cells., Stem Cell Res 2024 Oct; 81(): 103589.
-
2024High-throughput screening identifies broad-spectrum Coronavirus entry inhibitors., iScience 2024 Jun; 27(6): 110019.
-
2024Generation of IPi001-A/B/C human induced pluripotent stem cell lines from healthy amniotic fluid cells., Stem Cell Res 2024 Apr; 76(): 103350.
-
2024PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial., NPJ Vaccines 2024 Jan; 9(1): 10.
-
2023Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages., iScience 2023 Apr; 26(4): 106413.
-
2023Design and synthesis of naturally-inspired SARS-CoV-2 inhibitors., RSC Med Chem 2023 Mar; 14(3): 507-519.
-
2022High-Content RNAi Phenotypic Screening Unveils the Involvement of Human Ubiquitin-Related Enzymes in Late Cytokinesis, Cells 2022, 11(23), 3862.
-
2022Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2., J Exp Med 2022 Jul; 219(7): .
-
2022A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors., Antiviral Res 2022 May; 201(): 105272.
-
2021Interrogating RNA and protein spatial subcellular distribution in smFISH data with DypFISH, Volume 1, Issue 5, 27 September 2021, 100068.
-
+Voir la liste complète de publications